KORU Medical Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. The company is headquartered in Mahwah, New Jersey and currently employs 80 full-time employees. The firm is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The firm is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.
最新の財務諸表(Form-10K)によると、KORU Medical Systems Incの総資産は$28で、純損失は$-2です。
KRMDの主要な財務比率は何ですか?
KORU Medical Systems Incの流動比率は2.54、純利益率は-4.87、1株当たり売上高は$0.88です。
KORU Medical Systems Incの収益はセグメントまたは地域別にどのように分けられていますか?
KORU Medical Systems Inc の最大収益セグメントは Domestic Core で、最新の利益発表における収益は 25,214,613 です。地域別に見ると、United States が KORU Medical Systems Inc の主要市場であり、収益は 27,506,682 です。
KORU Medical Systems Incは収益を上げていますか?
いいえ、最新の財務諸表によると、KORU Medical Systems Incの純損失は$-2です。